S1PR2 antagonist alleviates oxidative stress-enhanced brain endothelial permeability by attenuating p38 and Erk1/2-dependent cPLA2 phosphorylation
Changchun Cao(Fujian Medical University), Shengnan Li(Nanjing Medical University), Junyu Mu(Nanjing Medical University), Yali Hong(Nanjing Medical University), Li Dai(Nanjing Medical University), Xiaofei Wang(Louisiana State University Health Sciences Center New Orleans), Chao Zhu(Nanjing Medical University), Lai Jin(Nanjing Medical University)
Cited by 51
Related Papers
Link between triglyceride-glucose-body mass index and future stroke risk in middle-aged and elderly chinese: a nationwide prospective cohort study
|Cardiovascular Diabetology|2024|104
<i>Mycoplasma genitalium</i>Infections in Asymptomatic Men and Men with Urethritis Attending a Sexually Transmitted Diseases Clinic in New Orleans
|Clinical Infectious Diseases|2002|98
Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults
|Cardiovascular Diabetology|2023|85
Retracted: Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target
|Journal of Medical Genetics|2018|75